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Summary
The Hedgehog (Hh) and Wingless (Wnt) families of
secreted signaling molecules have key roles in embry-
onic development and adult tissue homeostasis [1–3].
In the developing neural tube, Wnt and Shh, emanating
from dorsal and ventral regions, respectively, have
been proposed to govern the proliferation and survival
of neural progenitors [4–10]. Surprisingly, Shh is re-
quired for the growth and survival of cells in both ven-
tral and dorsal neural tube [11]. Here we demonstrate
that inhibition of Shh signaling causes a reduction in
Wnt-mediated transcriptional activation. This reduc-
tion requires Gli3. Assays in embryos and cell lines
indicate that repressor forms of the Hh-regulated
transcription factor, Gli3 (Gli3R), which are generated
in the absence of Hh signaling, inhibit canonical Wnt
signaling. Gli3R acts by antagonizing active forms of
the Wnt transcriptional effector, b-catenin. Consistent
with this, Gli3R appears to physically interact with the
carboxy-terminal domain of b-catenin, a region that in-
cludes the transactivation domain. These data offer an
explanation for the proliferative defects in Shh null
embryos and suggest a novel mechanism for crosstalk
between the Hh and Wnt pathways.
Results and Discussion
Repressor Forms of Gli3 Inhibit Canonical
Wnt Signaling
Shh signaling regulates the growth and survival of pro-
genitors in the neural tube [11]. In the absence of Shh,
an overall reduction in the size of the neural tube was
evident (Figure 1A). Surprisingly, this reduction in neural
tube growth did not appear to be confined to ventral
progenitors because mitotic cells were distributed
evenly along the dorsoventral axis. Moreover, apoptotic
figures were located in both dorsal and ventral regions
of the neural tube (Figure 1A and data not shown). Be-
cause Wnt signaling, derived from dorsal aspects of
the neural tube, has been suggested to regulate dorsal
progenitors, we analyzed the expression of the Wnt-
responsive gene Axin2 [4, 12]. Strikingly, compared to
littermate controls, Axin2 expression was reduced in
Shh null embryos (Figure 1A), suggesting that Wnt sig-
naling is decreased in the absence of Shh signaling.
*Correspondence: james.briscoe@nimr.mrc.ac.ukTo analyze this further, we directly measured canoni-
cal Wnt signaling activity by using reporter assays in
embryonic chick neural tubes (Figures 1B–1D). First, we
used a reporter consisting of the Axin2 promoter [12].
Transfection of Wnt3a increased by 2- to 3-fold the
Axin2 reporter activity. To test whether inhibiting Hh sig-
naling influenced the Wnt response of neural cells, we
used Ptc1Dloop2, a dominant active form of the Hh recep-
tor, Ptc1, which inhibits Hh signaling cell autonomously
at the receptor level [13]. In embryos cotransfected with
Wnt3a and Ptc1Dloop2, the ability of Wnt3a to induce the
Axin2 reporter activity was greatly reduced (Figure 1C).
To confirm an inhibitory effect of Ptc1Dloop2 on Wnt
signaling, we performed similar assays with the well-
established TCF-luciferase reporter plasmid, pTOP-
FLASH. In this reporter, six optimized TCF binding sites
control the expression of luciferase [14]. Transfection of
a Wnt3a expression plasmid increased pTOPFLASH
activity 10- to 20-fold in neural cells (Figure 1D). Cotrans-
fection with Ptc1Dloop2 reduced significantly the pTOP-
FLASH activity induced by Wnt3a. Together, these
results suggest that blockade of Shh signaling de-
creases the responsiveness of neural cells to canonical
Wnt signaling.
The absence of the proliferation defects in Shh2/2;
Gli3xt/xt mutants [8] prompted us to examine Axin2 ex-
pression in these embryos.Axin2 expression was similar
in Shh2/2;Gli3xt/xt mutants to wild-type litter-mates (Fig-
ure 1E), indicating that the reduction of Wnt signaling
observed in the absence of Shh signaling is dependent
on Gli3. In the absence of Shh signaling, Gli3 is proteo-
lytically processed to a transcriptional repressor form,
termed Gli3R [15–20]. We therefore tested whether
a construct encoding Gli3R inhibited Wnt signaling.
Coelectroporation of Gli3R decreased the ability of
Wnt3a to induce pTOPFLASH activity (Figure 1F), indi-
cating that repressor forms of Gli3 inhibit canonical
Wnt signaling in neural cells. This suggests that endog-
enous forms of Gli3R mediate the inhibition of Wnt
signaling caused by Ptc1Dloop2. Consistent with this,
coelectroporation of a dominant-negative form of PKA,
which inhibits formation of Gli3R [19], rescues the inhib-
itory effects of Ptc1Dloop2 on Wnt signaling (see Figure S1
in the Supplemental Data available online). We did not
detect marked differences in Axin2 expression between
Gli3xt/xt mutants and their wild-type littermates (data not
shown). This is consistent with the absence of prolifera-
tion defects in the neural tube of Gli3-deficient mice [20]
and suggests that the levels of Gli3R necessary to affect
Wnt signaling are only achieved in the Shh2/2 back-
ground. This implies that sufficient Shh signaling nor-
mally reaches the dorsal neural tube to reduce Gli3R
below a level at which Wnt signaling is inhibited. To-
gether, the data suggest a model in which increased
levels of Gli3R formed in Shh-deficient mice are able to
inhibit Wnt signaling. This model explains the presence
of defects in the dorsal neural tube of Shh null embryos
despite the proproliferative activity of Wnt signaling.
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(A) Transverse sections at the thoracic level of E9.5 mice embryos. Anti-activated caspase3 antibody was used to detect apoptotic cells, and the
expression of the Wnt-responsive gene Axin2 was assayed by in situ hybridization. In Shh null embryos, apoptotic cells were detected in ventral
and dorsal (arrows) regions of the neural tube. The expression of Axin 2 was reduced in these embryos, suggesting a decrease in canonical Wnt
signaling in the absence of Shh. Two Shh2/2 embryos displaying the range of phenotypes are shown.
(B) Diagram of the electroporation of chick embryo neural tube.
(C and D) HH stage 11-12 chick embryos were coelectroporated with a reporter consisting of the firefly luciferase under the control of the Axin 2
promoter (0.3 mg/ml) (C) or pTOPFLASH (0.3 mg/ml) (D), a normalization plasmid consisting of a renilla luciferase under the control of a CMV pro-
moter (0.05 mg/ml) and either empty pCAGGS vector, Wnt3a (1 mg/ml), or Wnt3a and Ptc1Dloop2 (2 mg/ml). Total amount of DNA was adjusted to
3.35 mg/ml by appropriate empty vectors. The levels of firefly and renilla luciferase were measured 24 hr after the electroporation. Ptc1Dloop2,
which inhibits Shh pathway, decreased the response of neural cells to Wnt3a.
(E) Axin2 in situ hybridization performed on transverse sections at the thoracic level of wild-type and Shh2/2;Gli3xt/xt E9.5 mice embryos. Loss of
Gli3 rescues the reduction of Axin2 expression observed in the spinal cord of Shh2/2 mutants (A).
(F) In ovo luciferase assay performed as described in (C) and (D) and with pTOPFLASH as a reporter and a construct encoding the repressor form
of Gli3 (Gli3R) (2 mg/ml). Gli3R was sufficient to decrease the response of neural cells to Wnt3a.
(G) Luciferase assay in cultured cells. HEK293, HT-1080, and COS-7 cells were transfected with pTOPFLASH (250 ng), CMV renilla luciferase
normalization plasmid (10 ng), and Gli1, Gli3R, or empty pCAGGS (50 ng). Cells were cultured in the absence or presence of Wnt3a conditioned
media and luciferase activities measured 24 hr after transfection. The activity of a reporter containing mutated TCF binding sites (pFOPFLASH)
was also assayed in HEK293 cells. Forced expression of Gli3R inhibited the response to Wnt3a in each of the cell lines tested.
(H) TNF signaling assay in HEK293 cells. Cells were transfected with an NFkB firefly luciferase reporter construct (100 ng), CMV renilla luciferase
normalization plasmid (10 ng), and Gli3R (20 ng) or pCAGGS empty vector. After 24 hr, cells were transferred to 0.5% serum media supplemented
as indicated with TNF (40 ng/ml). After overnight incubation, the luciferase activities were measured. The response to TNF was unaffected by
Gli3R.
Error bars indicate standard deviation.To determine whether Gli3R inhibited Wnt signaling in
cells other than neural progenitors, we performed
pTOPFLASH assays in a panel of Wnt-responsive cell
lines (Figure 1G). Cells were transfected with reporter
plasmids either alone, with Gli3R, or with Gli1, a Gli pro-
tein that acts solely as a transcriptional activator [16, 17].
In each cell line, Wnt3a-induced activity was markedly
reduced by cotransfection with Gli3R (Figure 1G). In
contrast, the level of pTOPFLASH activity was not sig-
nificantly affected in cells transfected with Gli1 in thepresence or absence of Wnt3a treatment (Figure 1G),
supporting the idea that pTOPFLASH does not respond
directly to Gli activity. In addition, the activity of a re-
porter consisting of mutated TCF binding sites, unable
to interact with TCF (pFOPFLASH), was unaffected in
the same experimental conditions (Figure 1G).
To rule out the possibility that the effects of Gli3R were
nonspecific, we tested the ability of TNF to induce NfkB/
Rel activity. TNF treatment of HEK293 cells induced an
8-fold increase in NfkB/Rel activity, and transfection of
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547Figure 2. Gli3R Inhibits b-Catenin Activity
(A) Diagram of the canonical Wnt signaling
pathway.
(B) Luciferase assay in HEK293 cells with
TOPFLASH as a reporter (150 ng) and CMV
renilla luciferase (10 ng) as a normalization
plasmid. HEK293 cells were stimulated with
10 mM LiCl, an inhibitor of GSK3b, or trans-
fected with Wnt3a (100 ng), LRP6 (100 ng),
Dishevelled (Dsh) (100 ng), and a constitu-
tively active form of b-catenin (b-cateninAct)
(100 ng), in the presence of transfected
Gli3R (100 ng). Total amount of DNA was
adjusted to 360 ng with appropriate empty
vectors. Firefly and renilla luciferase activities
were assayed after 24 hr. Gli3R inhibited Wnt
pathway in each case.
(C) Wnt activity was assayed with pTOP-
FLASH in HEK293 cells transfected with
Gli3R (20 ng) or empty pCAGGS vector and
Lef1 fused to the transactivation domain of
b-catenin (Lef1-b-catenin) (100 ng). Gli3R
inhibited the activity of Lef1-b-catenin.
(D) Wnt activity was assayed with pTOP-
FLASH in HEK293 cells transfected with
Lef1 fused to the Vp16 transactivation do-
main (Lef1-Vp16) (100 ng) together with
Gli3R (20 ng) or empty pCAGGS vector.
Error bars indicate standard deviation.Gli3R did not affect the activity of TNF (Figure 1H). To-
gether, these data suggest that Gli3R selectively inhibits
canonical Wnt signaling in a range of cell types.
Gli3R Inhibits b-Catenin Activity
To ascertain at which step of the Wnt pathway (Fig-
ure 2A) Gli3R exerted its effects, we activated the Wnt
signaling at different levels and tested the ability of
Gli3R to inhibit the response (Figure 2B). Wnt signaling,
activated by transfection of Wnt3a, LRP6, and Dishev-
elled and by LiCl-mediated inhibition of GSK-3b, was
blocked by cotransfection of Gli3R. Moreover, Gli3R
inhibited the activity of a dominant active, stabilized
form of b-catenin lacking the first 87 amino acids (b-cat-
eninAct) [21] and a version of b-catenin lacking the GSK-
3b phosphorylation site necessary for its rapid degrada-
tion (data not shown) [22]. Forced expression of Gli1 did
not affect the activity of stabilized b-catenin, while a
construct encoding full-length Gli3, which is partially
processed in vivo, moderately reduced its activity
(data not shown). Consistent with the capacity of Gli3R
to affect the Wnt pathway by modulating b-catenin ac-
tivity, Gli3R expression inhibited pTOPFLASH activity
in a panel of colon cancer cells containing mutations
that stabilize endogenous b-catenin (Figure S2).
The results suggested that Gli3R exerts its action on
the Wnt pathway at or downstream of b-catenin. To de-
termine whether Gli3R inhibited TCF/Lef expression or
the interaction of TCF/Lef with b-catenin, we analyzed
the effect of Gli3R on the activity of constitutively active
b-catenin fusion constructs. The Wnt-independent in-
duction of pTOPFLASH activity by a fusion of the Lef1
HMG-box domain to the b-catenin transactivation do-
main (Lef1-b-catenin; diagrams describing the structure
of the constructs used in this work are indicated below)
[23] was inhibited by cotransfection of Gli3R (Figure 2C).In contrast, Gli3R had only minor inhibitory effect on the
ability of a Lef1-Vp16 fusion protein (Figure 2D) [23].
These data indicate that Gli3R does not mediate its
effects by repressing Tcf/Lef expression, inhibiting
Tcf/Lef DNA-binding ability, or blocking an interaction
between Tcf/Lef and b-catenin. Instead, the data favor
the idea that Gli3R inhibits Wnt signaling by inhibiting
the activity of b-catenin.
To confirm the inhibitory effect of Gli3R on b-catenin
activity, in vivo, we examined whether Gli3R abrogated
the ability of b-catenin to induce secondary axes in
Xenopus leavis embryos [24]. Injection of dominant ac-
tive b-catenin RNA (b-cateninAct) into a ventral-vegetal
blastomere of a 8-cell stage Xenopus embryo induced
the formation of secondary axes in w50% of embryos
(Figure 3). This effect was blocked by coinjection of a
dominant-negative form of Tcf-3 (DN-Tcf3) [25]. In a sim-
ilar manner, coinjection of Gli3R also blocked secondary
axis-inducing activity of b-catenin (Figure 3). These data
are consistent with those obtained in the luciferase as-
says and indicate that Gli3R is able to inhibit activated
b-catenin signaling in vitro and in vivo in a broad range
of different cell types.
Evidence for an Interaction between Gli3R
and b-Catenin
How does Gli3R inhibit b-catenin activity? Two proper-
ties that regulate b-catenin activity are its stability and
subcellular location [2]; however, Gli3R did not produce
observable changes in the subcellular distribution of
either transfected b-catenin protein or endogenous
b-catenin, and the stability of b-catenin was not de-
creased by Gli3R (Figure S3). Moreover, Gli3R expres-
sion did not significantly inhibit the expression of the
b-catenin cofactors CBP, p300, Brg1, Bcl9, or Pygopus
(Figure S3).
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548Figure 3. Gli3R Inhibits b-Catenin-Induced
Secondary Axis Formation in Xenopus
Embryos
(A) Representative stage 40 Xenopus em-
bryos injected with the indicated RNAs into
a single ventral-vegetal blastomere at the
8-cell stage.
(B) Summary of secondary axis assays.
Injection of a constitutively active form of
b-catenin (b-cateninAct) induced partial or
full secondary axes in most embryos. In
contrast, coinjection of Gli3R or a dominant-
negative form of Tcf-3 (DN-Tcf3) with b-cate-
nin resulted in far fewer embryos displaying
secondary axes.We therefore considered whether Gli3R physically
interacted with b-catenin. To examine this, we first per-
formed coimmunoprecipitation experiments in HEK293
cells (Figures 4A and 4B). Cells were transfected, either
alone or in combination, with b-cateninAct and Myc-
tagged Gli3R. b-catenin complexes were immunopre-
cipitated with an anti-b-catenin antisera that recognizes
endogenous and transfected b-catenin. In cells trans-
fected with Gli3R, anti-b-catenin was able to immuno-
precipitate Gli3R (Figure 4B). To discriminate between
Gli3R interaction with Lef/TCF proteins or b-catenin,
we performed immunoprecipitation experiments in cells
cotransfected with Myc-Gli3R and HA-Lef-1-b-catenin
or HA-Lef1-Vp16. Immunoprecipitation of Myc-Gli3R re-
vealed that HA-Lef1-b-catenin, but not HA-Lef1-Vp16,
complexed with Gli3R (Figure 4B). These data suggest
that Gli3R and b-catenin proteins may be present in
the same complex; moreover, the C-terminal transacti-
vation domain of b-catenin appears sufficient to mediate
the formation of this complex because the Lef-1-b-cate-
nin fusion protein contains only this region of b-catenin.
We next examined the ability of b-catenin to interact
with Gli3R in vitro (Figure 4C). We found that, compared
to GST-alone controls, Gli3R (Gli3 1-645) was enriched in
complexes containing GST-b-catenin [26]. Consistent
with the coimmunoprecipitation data, Gli3R was able to
interact with the last 200 amino acids of b-catenin
(GST-b-catenin CT), a region that includes the C-terminal
transactivation domain. In contrast, Gli3R interacted only
poorly with b-catenin lacking this region (GST-b-catenin-
D-CT). To determine the region of Gli3R that interacts
with b-catenin, we performed the same assays with sev-
eral truncated versions of Gli3 (Figure 4C). These data
suggest that regions of Gli3R amino terminal to amino
acid 395 are able to interact with b-catenin. Together,
the data support the idea that Gli3R and b-catenin can
form a complex and raise the possibility of a direct phys-
ical interaction between b-catenin and Gli3R (Figure 4C).
These data suggest a model in which a physical inter-
action between Gli3R and b-catenin inhibits the tran-
scriptional activity of b-catenin. The correlation between
the ability of Gli3R to interact with variants of b-cateninand the capacity to inhibit the transactivation supports
this idea: thus, Gli3R inhibits and coprecipitates with
b-cateninAct and Lef1-b-catenin but not Lef1-Vp16. Sup-
pressor of fused (SUFU) has previously been shown to
coimmunoprecipitate with both Gli proteins and b-cate-
nin and to inhibit b-catenin [27, 28]. Together with our
data, this raises the possibility that a complex between
b-catenin, Gli3R, and SUFU inhibits b-catenin activity,
perhaps by displacing b-catenin coactivators or by
recruiting corepressors. Whether SUFU is required for
the formation or function of a Gli-b-catenin complex
remains to be determined.
This study provides evidence that, in the absence of
Shh signaling, high levels of Gli3R act to inhibit Wnt sig-
naling. This explains why, in Shh-deficient mice, prolifer-
ation and survival defects are present along the entire
dorsoventral axis of the neural tube and why these de-
fects are rescued in Shh2/2;Gli3xt/xt mice. Crosstalk is
also evident in nonneural cells. These data therefore
raise the possibility that interactions between Shh and
Wnt signaling also influence some of the biological func-
tions of the two signaling pathways in other tissues.
Experimental Procedures
Mice
Embryos were generated from Shh+/2 [29] and Gli3+/Xt [30] mice.
Cells and Plasmids
All cell lines were cultured in standard conditions. TNFa was
obtained from Sigma. Transfections were carried out with the Lipo-
fectamine-Plus Reagent (Invitrogen). When required, transfected
cells were purified by GFP fluorescence by FACS. Gli3R consists
of aa 1–645 of human Gli3 fused to either 6X Myc or Flag tag at the
N terminus expressed from either pCAGGS-IRES-nlsGFP [31] or
pCS2 [32]. Both constructs show similar repressor properties in
cells and chick embryos (data not shown). Mouse Wnt3a (from
A. McMahon), human LRP6 (from X. He),XenopusDsh (from S. Sokol),
and Lef1-b-catenin and LEF1-Vp16 (from A. Hecht) were all in pCS2.
Immunofluorescence and In Situ Hybridization
Inmunofluorescence detection of apoptotic cells was performed
with a rabbit antibody detecting the activated form of caspase 3
(Cell Signaling). Secondary antibodies were from Jackson. Images
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549Figure 4. Gli3R Interacts with b-Catenin
(A) Schematic representations of the constructs used in the coimmunoprecipitation experiments.
(B) Coimmuniprecipitation assays. HEK293 cells were transfected with the indicated proteins. After 36 hr, cells were lysed and protein extracts
incubated overnight with the indicated antibodies and protein A sepharose (for the b-catenin antibody) or protein G sepharose (for the Myc and
HA antibodies). Then, beads were washed extensively and proteins fractionated by SDS-PAGE prior to immunobloting with the indicated
antibodies. At longer exposures, it was possible to detect coprecipitated Gli3R in cells that were not transfected with b-cateninAct, presumably
because of an interaction with endogenous b-catenin (see Figure S4). Note that lane order has been rearranged for clarity and the images of
coimmunoprecipitation shown correspond to longer exposure times than the images of the western blots of total lysates (original gel images
are available as supplemental data; see Figure S4). Total lysates are 1/10 of the material used for the coprecipitation reactions.
(C) In vitro interaction assay. GST-b-catenin full-length, GST-b-catenin-D-CT, GST-b-catenin-CT, or GST alone were incubated with in vitro trans-
lated fragments of Gli3 labeled with 35S Met. GST proteins were captured with Glutathione-Sepharose beads, then proteins were fractioned by
SDS-PAGE before autoradiography. The coomassie blue staining of GST proteins employed is shown. Input are 1/10 of the material used for the
in vitro interaction reactions. Results of the interaction assays are summarized diagrammatically. N-terminal regions of Gli3 interact in vitro with
the C-terminal region of b-catenin.were collected on a Zeiss Axioplan 2 fluorescence microscope. In
situ hybridization of Axin2 was performed as described [12].
Luciferase Assay
Luciferase measurements were performed with the Dual-Luciferase
Reporter Assay System (Promega). Axin2 promoter luciferase
reporter was obtained from F. Costantini [12]. TOPFLASH and
FOPFLASH reporters were obtained from Upstate Biotechnology.
NfkB reporter plasmid was obtained from Clontech. CMV-renilla
luciferase was obtained from Promega. Luciferase assays in embry-
onic chick neural tubes have been described previously [33].
Xenopus Secondary Axis Assay
Capped RNA was synthesized and injected into the marginal zone of
one of ventral-vegetal blastomeres in 8-cell stage Xenopus em-
bryos. The amount injected was: b-catenin 200 pg; LacZ, Gli3R,
DN-Tcf3 250 pg. The embryos were incubated until stage 40 and cat-
egorized into three groups; 2 axes (with an ectopic axis with eyes
and cement gland), 1 axis + 1 partial axis (with a clear secondary
axis without any eye structure), and 1 axis.
Coimmunoprecipitation
Transfected HEK293 cells were lysed with lysis buffer (50 mM Tris-
HCl [pH 7.5], 1% Triton X-100, 0.05% SDS, and 0.2% BSA) contain-
ing Halt protease inhibitor cocktail (Pierce). Protein extracts were
incubated overnight at 4C with 1 ml of rabbit anti-b-catenin antibody(Sigma) and protein A sepharose (Pharmacia) or 1 ml of mAb anti-
Myc antibody 9B11 (Cell Signaling) and protein G sepharose
(Pharmacia) or 4 ml of rat Ab anti-HA antibody 3F10 (Roche) and
protein G sepharose. Then the beads were washed 4 times with
50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and
0.05% SDS and two times with PBS. The material immunoprecipi-
tated was fractioned by SDS-PAGE, transferred to a nitrocellulose
membrane, and detected by immunoblot with the mAb 9E10 (Santa
Cruz) to detect the myc epitope of Gli3R, or the Ab 3F10 to detect the
HA epitope.
In Vitro Protein Binding Assays
GST-b-catenin full length was kindly provided by R. Kemler [26]. This
construct was used to generate forms that lack (GST-b-catenin-
D-CT) or contain only (GST-b-catenin CT) the last 200 amino acids
of b-catenin sequence. Recombinant GST proteins were expressed
in E. coli and purified with Glutathione Sepharose beads. Gli3R was
produced with the TNT in vitro transcription/translation system
(Promega) according to the manufacturer’s instructions. 10 ml of
translation reactions were incubated with GST or GST-b-catenin in
150 mM KCl, 20 mM HEPES (pH 7.9), 0.1% NP40, 5 mM MgCl2,
0.2% BSA, and the Halt protein inhibitors cocktail (Pierce) during
5 hr at 4C. The beads were washed four times in 150 mM KCl,
20 mM HEPES (pH 7.9), 0.1% NP-40, 5 mM MgCl2, and protease in-
hibitors, and the bound proteins were resolved on SDS-PAGE and
revealed by autoradiography.
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Supplemental Data include four figures and Experimental Pro-
cedures and can be found with this article online at http://www.
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